Cabaletta Bio Files Q1 2025 10-Q
Ticker: CABA · Form: 10-Q · Filed: May 15, 2025 · CIK: 1759138
Sentiment: neutral
Topics: 10-Q, biotech, financials
TL;DR
Cabaletta Bio's Q1 2025 10-Q is in. Check financials & biz updates.
AI Summary
Cabaletta Bio, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported financial results and provided updates on its business operations. Key financial figures and operational details are presented in the filing, which covers the first quarter of 2025.
Why It Matters
This filing provides investors with the latest financial health and operational status of Cabaletta Bio, Inc., crucial for understanding its current performance and future prospects.
Risk Assessment
Risk Level: medium — Biotech companies often carry higher risk due to the nature of drug development and regulatory hurdles.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-15 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Cabaletta Bio, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250515 (date) — Filing date
- 267-759-3100 (phone_number) — Business phone number
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 15, 2025.
What is the company's primary business sector?
Cabaletta Bio, Inc. is in the BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) sector, SIC code 2836.
What is the company's business address?
The business address is 2929 ARCH STREET, SUITE 600, PHILADELPHIA, PA 19104.
What is the company's phone number?
The company's business phone number is (267) 759-3100.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Cabaletta Bio, Inc. (CABA).